X T L Biopharmaceuticals reported $946.24M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2.38M 172K Mar/2026
Bioline Rx USD 2.61B 0 Dec/2025
Teva Pharmaceutical Industries USD 1.16B 1000K Jun/2026
X T L Biopharmaceuticals USD 946.24M 64.86M Dec/2025